Alpheus begins multi-centre study for butterfly GBM
Patient recruitment is taking place at the Dent Neurologic Institute, US, with further clinical trial sites anticipated to join.
News
MSD’s Phase IIb study of tulisokibart achieves primary endpoint
Lilly reports comparative data from ACHIEVE-3 and PIONEER PLUS studies
Patient enrolment concludes in Vasomune’s Phase IIa Pegevongitide trial
Innovent expands Phase III MarsLight-11 trial to non-squamous NSCLC
Clywedog reports final Phase Ib trial results for balomenib
Roivant reports top-line data from IMVT-1402 CLE trial
Otsuka and Ionis report positive data in Phase III FUSION trial of ulefnersen
